Ying Zhao1, Ailian Liu1, Jingjun Wu1, Dahua Cui1, Tao Lin1, Qingwei Song1, Xin Li2, Tingfan Wu2, Yan Guo3, Lizhi Xie3, and Jingjing Cui4
1The First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Translational Medicine Team, GE Healthcare, Shanghai, China, 3GE Healthcare, Beijing, China, 4Huiying Medical Technology Inc., Beijing, China
Synopsis
In the current study, multi-sequence MRI radiomics
nomogram was demonstrated to be capable to predict two-year recurrence in hepatocellular
carcinoma after partial hepatectomy, which will provide more prognostic
information and facilitate clinical management.
Purpose
To investigate the application of multi-sequence MRI
radiomics nomogram to predict two-year recurrence in hepatocellular carcinoma
after partial hepatectomy.Introduction
Hepatocellular
carcinoma (HCC) is the sixth most common cancer and ranks as the fourth cause
of cancer-related death worldwide[1]. Partial hepatectomy with
curative intent has been proved as one of the most important strategies for HCC
patients at early-stage[2]. Nevertheless, up to 70% of HCC patients
who underwent partial hepatectomy experienced a subsequent recurrence within 5
years. The time to recurrence is an independent survival factor, and patients
with early recurrence (with in 2 years) tend to have lower overall survival
than those with late recurrence[3, 4]. Thus, it is necessary to
explore an non-invasive method of preoperative risk stratification to guide
further surveillance and treatment. Radiomics is a rapidly growing field that
converts medical images into high-dimensional quantitative features through
different algorithms, potentially aidding in cancer detection, diagnosis,
treatment response assessment, and prognosis prediction. Therefore,
multi-sequence MRI radiomics nomogram was introduced in the present study to
evaluate its clinical application performance in predicting two-year recurrence
of HCC after partial hepatectomy.Materials and Methods
This retrospective
study enrolled 105 patients who were pathologically confirmed as HCC, including
55 early recurrence HCC (within two-year recurrence) and 50 non-early
recurrence HCC. All patients have underwent preoperative MR examinations,
including in-phase T1WI, out-phase T1WI, T2WI, DWI and LAVA dynamic contrast
enhanced MRI (arterial, venous and delayed phase). The 70% samples were
randomly selected as training set and the others were testing set. On the MR
images, two radiologists manually outlined the ROIs which enclosed the boundary
of target lesions and extracted 1029 radiomics features, which were classified
as first order statistic, shape, second-order statistics, and higher order
statistics features. Then, the Spearman correlation analysis, least absolute
shrinkage and selection operator (LASSO) algorithm, and stepwise regression
method were performed to identify the most predictive radiomics features. The
radiomics scores regarding combination of different MR sequences using
multivariate logistic regression method for predicting early recurrence were
developed, thus we obtained the optimal radiomics score. We also built
clinicopathologic-radiologic nomogram and radiomics nomogram (integrating the
optiminal radiomics score and clinicopathologic-radiologic independent risk
factors). Diagnostic performance was evaluated by receiver operating
characteristic (ROC) analysis.Results
The optimal radiomics score, which selecting
radiomics features from in-phase T1WI, out-phase T1WI, T2WI and enhanced MR
sequences, and obtained the optimal AUC ( 0.828 in the training set, and 0.792
in the testing set). The radiomics score using the follow formula: Rad_score = 0.0378-0.2340*OUT_wavelet.LHH_glcm_Correlation-
0.1147*OUT_wavelet.HLH_glcm_Correlation-0.0773*A_wavelet.HHH_glrlm_ShortRunLowGrayLevelEmphasis+0.2750*A_wavelet.LLL_glszm_LargeAreaHighGrayLevelEmphasis+0.6019*V_wavelet.LLH_firstorder_Kurtosis+0.2537*V_wavelet.HHH_firstorder_Mean.
The clinicopathologic-radiologic nomogram was constructed including age,
pathological grading, tumor size, tumor number, intratumor necrosis and
pseudo-capsule (Fig. 1a). The radiomics nomogram was built by
incorporating the radiomics score into clinicopathologic-radiologic characters
(age, pathological grading and intratumor necrosis) (Fig. 1b). The
diagnostic performance of the optimal radiomics score,
clinicopathologic-radiologic nomogram and radiomics nomogram were shown in Table
1. In the testing set, the AUC of the radiomics score was 0.792, an
accuracy of 0.750, a sensitivity of 0.765 and a specificity of 0.733. The AUC
of the clinicopathologic-radiologic nomogram was 0.773, an accuracy of 0.688, a
sensitivity of 0.647 and a specificity of 0.733. The AUC of the radiomics
nomogram was 0.898, an accuracy of 0.812, a sensitivity of 0.765 and a
specificity of 0.867.Discussion
The multi-sequence
MRI radiomics based strategy has shown great potential in predicting early
recurrence of HCC, and radiomics nomogram incorporating the radiomics score and
clinicopathologic-radiologic characters, seems more useful for accurate
prediction of early recurrence. Discriminative features in the optimal
radiomics score are composed of specific categories: two histogram-based
features (kurtosis and mean), two GLCM-based features (2 of correlation), one
GLRLM-based feature (ShortRunLowGrayLevelEmphasis), and one GLSZM-based feature
(LargeAreaHighGrayLevelEmphasis). In the present study, the optimal radiomics
score demonstrated satisfactory discriminative power both in the training and
validation cohorts (AUC = 0.828 and 0.792, respectively). Meanwhile, the
radiomics nomogram demonstrated promising results (AUC 0.898, sensitivity 0.765
and specificity 0.867 in the testing set), which be comparative to the results
studied by Zhang (AUC 0.841, sensitivity 0.913 and specificity 0.750 in the
testing set)[5].Conclusion
Multi-sequence MRI-based radiomics nomogram
demonstrated good discriminative ability in predicting two-year recurrence in
hepatocellular carcinoma after partial hepatectomy, which will provide more
prognostic information and facilitate clinical management.Acknowledgements
No acknowledgement found.References
[1] Villanueva A . Hepatocellular carcinoma. N Engl
J Med. 2019; 380: 1450–62.
[2] Forner A, Reig M, Bruix J. Hepatocellular
carcinoma. Lancet. 2018; 391: 1301–14.
[3] Feng J, Chen J, Zhu R, et al. Prediction of
early recurrence of hepatocellular carcinoma within the Milan criteria after
radical resection. Oncotarget. 2017; 8(38): 63299–3310.
[4] Cheng Z, Yang P, Qu S, et al. Risk factors and
management for early and late intrahepatic recurrence of solitary
hepatocellular carcinoma after curative resection.HPB (Oxford). 2015; 17(5): 422-7.
[5] Zhang Z, Jiang H, Chen J, et al.
Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR
imaging for early postoperative recurrence prediction. Cancer Imaging. 2019;
19(1): 22.